Interferon as an alternative to purine analogues in the treatment of hairy cell leukaemia

British Journal of Haematology

Volumn 148, Issue 4, 2010, Pages 664-665

  Benz, Rudolf ^a   Stussi, Georg ^b   Fehr, Joerg ^b  

^a Kantonsspital Muensterlingen   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Cladribine; Hairy cell leukaemia; Malignancy; Non Hodgkin lymphoma

Indexed keywords

ALPHA INTERFERON; CLADRIBINE; PENTOSTATIN;

FOLLOW UP; HAIRY CELL LEUKEMIA; HUMAN; LETTER; LOW DRUG DOSE; PRIORITY JOURNAL; SPLENECTOMY; TREATMENT RESPONSE;

ANTINEOPLASTIC AGENTS; HUMANS; INTERFERON-ALPHA; LEUKEMIA, HAIRY CELL; RESEARCH DESIGN;

EID: 75149163273     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.07948.x     Document Type: Letter

References (9)

1. Benz, R., Siciliano, R.D., Stussi, G. Fehr, J. (2009) Long-term interferon-alpha and low-dose maintenance therapy in hairy cell leukemia. European Journal of Haematology, 82, 194 200.
2. Chadha, P., Rademaker, A.W., Mendiratta, P., Kim, B., Evanchuk, D.M., Hakimian, D., Peterson, L.C. Tallman, M.S. (2005) Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CDA): long-term follow-up of the Northwestern University experience. Blood, 106, 241 246.
3. Cheson, B.D., Sorensen, J.M., Vena, D.A., Montello, M.J., Barrett, J.A., Damasio, E., Tallmann, M., Annino, L., Conners, J., Coiffier, B. Lauria, F. (1998) Treatment of hairy cell leukemia with 2-chlorodeoxyadneosine via the group c protocol mechanism of the national cancer institute: a report of 979 patients. Journal of Clincal Oncology, 16, 3007 3015.
4. Damasio, E.E., Clavio, M., Masoudi, B., Isaza, A., Spriano, M., Rossi, E., Casciaro, S., Cerri, R., Risso, M., Nati, S., Siccardi, M., Truini, M. Gobbi, M. (2000) Alpha-interferon as induction and maintenance therapy in hairy cell leukemia: a long-term follow-up analysis. European Journal of Haematology, 64, 47 52.
5. Else, M., Dearden, C.E., Matutes, E., Garcia-Talavera, J., Rohatiner, A.Z., Johnson, S.A., O'Connor, N.T., Haynes, A., Osuji, N., Forconi, F., Lauria, F. Catovsky, D. (2009) Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis. British Journal of Haematology, 145, 733 740.
6. Goodman, G.R., Burian, C., Koziol, J.A. Saven, A. (2003) Extended follow-up of patients with hairy cell leukemia after treatment with cladribine. Journal of Clinical Oncology, 21, 891 896. (Pubitemid 46606450)
7. Hisada, M., Chen, B.E., Jaffe, E.S. Travis, L.B. (2007) Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study. Journal of the National Cancer Institute, 99, 215 222.
8. Jehn, U., Bartl, R., Dietzfelbinger, H., Haferlach, T. Heinemann, V. (2004) An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine. Leukemia, 18, 1476 1481.
9. Saven, A., Burian, C., Koziol, J.A. Piro, L.D. (1998) Long-term follow-up of patients with hairy cell leukemia after cladribine treatment. Blood, 92, 1918 1926.